(Q45866599)

17 December 2017

title

Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes (English)

1 reference

17 December 2017

1 reference

Kobayashi T

1

1 reference

17 December 2017

Okamoto K

2

1 reference

17 December 2017

Kobata T

3

1 reference

17 December 2017

Hasunuma T

4

1 reference

17 December 2017

Kato T

5

1 reference

17 December 2017

Hamada H

6

1 reference

17 December 2017

Nishioka K

7

1 reference

17 December 2017

publication date

1 March 2000

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

7

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

527-533

1 reference

17 December 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Apoptosis in rheumatoid arthritis: a novel pathway in the regulation of synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Apoptosis in rheumatoid arthritis synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

The basic science of gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

FADD gene therapy for malignant gliomas in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: implications for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Adenoviral-mediated gene transfer to rabbit synovium in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Gene therapy for rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Suppression of collagen-induced arthritis through adenovirus-mediated transfer of a modified tumor necrosis factor alpha receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

7 January 2021

Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

7 January 2021

Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

7 January 2021

Activation of transcription factor NF-kappa B in human synovial cells in response to tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301127

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301127

1 reference

17 December 2017

Dimensions Publication ID

1003104512

0 references

1 reference

17 December 2017